DR. AMANDINE GRIMM
Research in Brain Cell Biology and Energy Metabolism
at the University of Basel, Switzerland
About
I am a neurobiologist at the University of Basel and the University Psychiatric Clinics (UPK) in Switzerland. I lead a team focused on Cell Biology and Energy Metabolism. My primary interest is studying brain mitochondria's role in health and disease states. Mitochondria are crucial organelles responsible for energy production in cells. Defects in mitochondrial function can lead to cellular impairments, from subtle alterations in neuronal function to neurodegeneration. The main objective of my research is to gain a deeper understanding of mitochondrial function and disease-related mitochondrial impairments to characterize the biological basis for therapeutic interventions.
Background
I completed a joint PhD thesis between the University of Strasbourg (France, specializing in Neuroscience) and the University of Basel (Switzerland, specializing in Pharmaceutical Sciences). The project was titled: 'Mitochondria, neurosteroids, and circadian rhythms: implications in health and disease states.' This joint PhD aimed to deepen our understanding of mitochondrial function regulation by identifying key factors, both endogenous and exogenous, critical in controlling mitochondrial bioenergetics and reduction/oxidation (redox) state. The results I obtained contribute to a better understanding of mitochondrial function and could have multiple implications regarding the regulation of metabolic homeostasis in health and disease states associated with mitochondrial impairments (e.g., in Alzheimer’s disease) and/or circadian disruption.
After completing my first postdoctoral project in the laboratory of Prof. Anne Eckert at the University of Basel (Switzerland), I undertook a research stay abroad. I chose to work in the laboratory of Prof. Jürgen Götz at the Queensland Brain Institute, University of Queensland, Brisbane, Australia, an internationally renowned expert with significant expertise in modeling Alzheimer's disease in vivo, dissecting pathomechanisms, and developing therapeutic interventions. This international collaboration aimed to enhance our understanding of Alzheimer’s disease-related impairments, such as Tau protein aggregation and oxidative injuries, in neurodegeneration using state-of-the-art technology, including high-end microscopy techniques. By combining optogenetics with the use of fluorescent biosensors and photoactivatable green fluorescent protein, I demonstrated that neurons restrict the local increase in mitochondria-derived oxidative stress and the decrease in energy production to the damaged neuronal compartment by quarantining mitochondria.
I am currently working as a junior group leader and conducting independent research at the Research Platform of Molecular and Cognitive Neurosciences at the University of Basel. I am especially interested in further studying the role of neuronal mitochondria and brain bioenergetic metabolism in both healthy and diseased states. My research focuses on the role of mitochondria in neurodegenerative disorders, particularly in Tau protein-related frontotemporal dementia. Our current projects aim to investigate intercellular mitochondria transfer between neurons and astrocytes.
Research interests
-
Intercellular mitochondria transfer, mitochondrial transplantation
-
Tauopathies, Alzheimer’s disease, neurodegenerative diseases
-
Mitochondrial function in cancer (glioblastoma)
-
Intracellular cholesterol homeostasis, neurosteroids
-
Endoplasmic reticulum – mitochondria coupling
-
Bioenergetics, redox signaling, role of mitochondria in neurodegeneration, mitophagy
-
Circadian rhythms
Teaching activity
-
Supervision of Master and PhD students
-
Lectures given at the University of Basel
-
Introduction to Bioenergetics: Physiology of mitochondria and pathology and neurodegeneration
-
Psychopharmacology and Neurotoxicology: Cellular assays and Mitochondrial toxicity
-
Collaborators
-
Prof. Dr. Anne Eckert, Neurobiology Laboratory for Brain Aging and Mental Health, UPK, Basel, Switzerland
-
Prof. Dr. Jürgen Götz, Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, University of Queensland, Brisbane, Autralia
-
Prof. Dr Paolo Paganetti, Università della Svizzera Italiana, Torricella-Taverne, Switzerland
-
Dr. Kevin Richetin, Center for Psychiatric Neuroscience, CHUV-Department of Psychiatry, Lausanne, Switzerland
-
Dr. Celeste Karch, Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA
-
Dr. Demetrius Lloyd, Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, USA